37542299|t|VPS35 and alpha-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
37542299|a|BACKGROUND: Mutations in the vacuolar protein sorting 35 ortholog (VPS35) gene cause late-onset, autosomal dominant Parkinson's disease (PD), with a single missense mutation (Asp620Asn, D620N) known to segregate with disease in families with PD. The VPS35 gene encodes a core component of the retromer complex, involved in the endosomal sorting and recycling of transmembrane cargo proteins. VPS35-linked PD is clinically indistinguishable from sporadic PD, although it is not yet known whether VPS35-PD brains exhibit alpha-synuclein-positive brainstem Lewy pathology that is characteristic of sporadic cases. Prior studies have suggested a functional interaction between VPS35 and the PD-linked gene product alpha-synuclein in lower organisms, where VPS35 deletion enhances alpha-synuclein-induced toxicity. In mice, VPS35 overexpression is reported to rescue hippocampal neuronal loss in human alpha-synuclein transgenic mice, potentially suggesting a retromer deficiency in these mice. METHODS: Here, we employ multiple well-established genetic rodent models to explore a functional or pathological interaction between VPS35 and alpha-synuclein in vivo. RESULTS: We find that endogenous alpha-synuclein is dispensable for nigrostriatal pathway dopaminergic neurodegeneration induced by the viral-mediated delivery of human D620N VPS35 in mice, suggesting that alpha-synuclein does not operate downstream of VPS35. We next evaluated retromer levels in affected brain regions from human A53T-alpha-synuclein transgenic mice, but find normal levels of the core subunits VPS35, VPS26 or VPS29. We further find that heterozygous VPS35 deletion fails to alter the lethal neurodegenerative phenotype of these A53T-alpha-synuclein transgenic mice, suggesting the absence of retromer deficiency in this PD model. Finally, we explored the neuroprotective capacity of increasing VPS35 expression in a viral-based human wild-type alpha-synuclein rat model of PD. However, we find that the overexpression of wild-type VPS35 is not sufficient for protection against alpha-synuclein-induced nigral dopaminergic neurodegeneration, alpha-synuclein pathology and reactive gliosis. CONCLUSION: Collectively, our data suggest a limited interaction of VPS35 and alpha-synuclein in neurodegenerative models of PD, and do not provide support for their interaction within a common pathophysiological pathway.
37542299	0	5	VPS35	Gene	55737
37542299	10	25	alpha-Synuclein	Gene	20617
37542299	55	72	neurodegeneration	Disease	MESH:D019636
37542299	93	112	Parkinson's disease	Disease	MESH:D010300
37542299	143	179	vacuolar protein sorting 35 ortholog	Gene	55737
37542299	181	186	VPS35	Gene	55737
37542299	230	249	Parkinson's disease	Disease	MESH:D010300
37542299	251	253	PD	Disease	MESH:D010300
37542299	289	298	Asp620Asn	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;OriginalGene:65114;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:10090;CA#:259758
37542299	300	305	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;OriginalGene:65114;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:10090;CA#:259758
37542299	356	358	PD	Disease	MESH:D010300
37542299	364	369	VPS35	Gene	55737
37542299	506	511	VPS35	Gene	55737
37542299	519	521	PD	Disease	MESH:D010300
37542299	568	570	PD	Disease	MESH:D010300
37542299	609	614	VPS35	Gene	55737
37542299	615	617	PD	Disease	MESH:D010300
37542299	633	648	alpha-synuclein	Gene	6622
37542299	668	682	Lewy pathology	Disease	MESH:D005598
37542299	787	792	VPS35	Gene	55737
37542299	801	803	PD	Disease	MESH:D010300
37542299	824	839	alpha-synuclein	Gene	6622
37542299	866	871	VPS35	Gene	65114
37542299	890	905	alpha-synuclein	Gene	6622
37542299	914	922	toxicity	Disease	MESH:D064420
37542299	933	938	VPS35	Gene	65114
37542299	988	1001	neuronal loss	Disease	MESH:D009410
37542299	1011	1026	alpha-synuclein	Gene	6622
37542299	1237	1242	VPS35	Gene	55737
37542299	1247	1262	alpha-synuclein	Gene	20617
37542299	1305	1320	alpha-synuclein	Gene	20617
37542299	1362	1392	dopaminergic neurodegeneration	Disease	MESH:D009422
37542299	1441	1446	D620N	ProteinMutation	tmVar:p|SUB|D|620|N;HGVS:p.D620N;VariantGroup:0;OriginalGene:65114;CorrespondingGene:55737;RS#:188286943;CorrespondingSpecies:10090;CA#:259758
37542299	1447	1452	VPS35	Gene	55737
37542299	1478	1493	alpha-synuclein	Gene	20617
37542299	1525	1530	VPS35	Gene	65114
37542299	1603	1607	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:1;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
37542299	1608	1623	alpha-synuclein	Gene	6622
37542299	1685	1690	VPS35	Gene	55737
37542299	1692	1697	VPS26	Gene	9559
37542299	1701	1706	VPS29	Gene	51699
37542299	1742	1747	VPS35	Gene	55737
37542299	1820	1824	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:1;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
37542299	1825	1840	alpha-synuclein	Gene	6622
37542299	1912	1914	PD	Disease	MESH:D010300
37542299	1986	1991	VPS35	Gene	55737
37542299	2036	2051	alpha-synuclein	Gene	6622
37542299	2065	2067	PD	Disease	MESH:D010300
37542299	2123	2128	VPS35	Gene	55737
37542299	2170	2185	alpha-synuclein	Gene	20617
37542299	2201	2231	dopaminergic neurodegeneration	Disease	MESH:D009422
37542299	2233	2248	alpha-synuclein	Gene	20617
37542299	2263	2279	reactive gliosis	Disease	MESH:D005911
37542299	2349	2354	VPS35	Gene	65114
37542299	2359	2374	alpha-synuclein	Gene	20617
37542299	2406	2408	PD	Disease	MESH:D010300
37542299	Association	MESH:D064420	65114
37542299	Association	MESH:D010300	RS#:188286943;HGVS:p.D620N;CorrespondingGene:55737
37542299	Positive_Correlation	MESH:D064420	6622
37542299	Association	MESH:D009422	RS#:188286943;HGVS:p.D620N;CorrespondingGene:55737
37542299	Association	MESH:D010300	55737
37542299	Association	MESH:D009410	65114
37542299	Association	MESH:D005598	6622
37542299	Association	MESH:D009422	55737
37542299	Association	55737	6622
37542299	Association	20617	55737
37542299	Association	MESH:D010300	6622
37542299	Association	65114	6622

